Polyclonal Antibodies Market Players:
- Abcam plc
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Bio-Rad Laboratories, Inc.
- GenScript Biotech Corporation
- BioLegend, Inc.
- Cell Signaling Technology, Inc.
- Rockland Immunochemicals Inc.
- Agilent Technologies, Inc.
- Fitzgerald Industries International
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of polyclonal antibodies is assessed at USD 1.8 billion.
The global polyclonal antibodies market size was valued at over USD 1.72 billion in 2025 and is expected to register a CAGR of over 5.3%, exceeding USD 2.88 billion revenue by 2035.
Asia Pacific polyclonal antibodies market achieves a 47% share by 2035, driven by the extensive use of polyclonal antibodies in immunohistochemistry and their role in diagnostic and therapeutic interventions.
Key players in the market include Abcam plc, Thermo Fisher Scientific Inc., Merck KGaA, Bio-Rad Laboratories, Inc., GenScript Biotech Corporation, BioLegend, Inc., Cell Signaling Technology, Inc., Rockland Immunochemicals Inc., Agilent Technologies, Inc., Fitzgerald Industries International.
